(Q67675052)

English

Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2′-deoxycytidine against human leukemic cells of different phenotype

scientific article published on 01 January 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2′-deoxycytidine against human leukemic cells of different phenotype (English)

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

author name string

R. L. Momparler

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700231

2 November 2022

N. Onetto-Pothier

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700231

2 November 2022

L. F. Momparler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1700231

2 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1700231

2 November 2022

publication date

1 January 1990

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:014521269090068K?httpAccept=text/xml

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

https://api.elsevier.com/content/article/PII:014521269090068K?httpAccept=text/plain

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Leukemia Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

755-760

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

3

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA

6

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

8

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia

9

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine

10

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Cellular differentiation, cytidine analogs and DNA methylation

11

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

DNA Methylation and Gene Function

14

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine

15

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia

17

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia

18

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

High-performance Liquid Chromatographic Analysis of Chemical Stability of 5-aza-2′-Deoxycytidine

19

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

DNA hypermethylation and changes in gene expression may be related to the chemotherapeutic action of cytarabin

21

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells

22

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Do different therapies of AML produce different outcomes?

24

1 reference

10.1016/0145-2126(90)90068-K

https://api.crossref.org/works/10.1016/0145-2126(90)90068-K

2 November 2022

Identifiers

10.1016/0145-2126(90)90068-K

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1700231%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67675052&oldid=1762788065"